January 2024

The expansion of research indications of CTLA4 is a major trend in the market NEW YORK, Jan. 25, 2024 /PRNewswire/ — The CTLA4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market is estimated to grow by USD 2.23 billion from  2023 to 2028, growing at a CAGR of 15.11%. High targ

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: